Latest news for Amadeus IT Gr (OTC:AMADF) Stock

Founded in 1987 by four major European airline carriers (Air France, Lufthansa, Iberia, and SAS), Amadeus became the world's second global distribution system operator, or GDS, after Sabre's development in the 1960s and 1970s. Today, among the top three GDS operators that control nearly 100% of industry revenue, Amadeus' 40%-plus market share ranks as the largest. Overall, Amadeus' GDS segment represented 56% of total prepandemic sales in 2019. Additionally, the company has an expanding IT solutions division (44% of 2019 revenue) that addresses the airline, airport, rail, hotel, and travel agency markets. Transaction fees, which are tied to volume and not price, account for the bulk of consolidated sales and profits.

News

Intraday Update

Markets

Movers

Trading Ideas

ABCE

ACST

AIPUY

ALEAFIA HEALTH INC ORD by Aleafia Health Inc.

ALEAF

ALTM

AMADF

AMCX

ANLDF

ANZFF

APTS

APVO

AQARF

ARCH

ASBRF

ASIX

ATRO

ATROB

ATUSF

AWCMY

AXION VENTURES INC by Axion Ventures Inc.

AXNVF

BBDO

BBSI

BCII

BFCH

BKUCF

BMMJ

BORR

BPAQF

BPMP

BRID

BRRAY

BUHPF

CANNABIS ONE HLDGS INC by Cannabis One Holdings Inc.

CAAOF

CANNABIS WHEATON INCOME by Cannabis Wheaton Income Corp.

CBWTF

CCDBF

CCLLF

CCLP

CDEV

CEQP

CHOOF

CHRRF

CJPRY

CJREF

CLDT

CLVLY

CNDT

CNXM

COKE

CRON

CWBHF

CWYUF

CYBL

DAKT

DCIX

DGEAF

DLNDY

DLTH

DNKLY

DRTT

EARS

EBIX

ECAOF

EMERALD HEALTH THERAPUTCS by Emerald Health Therapeutics Inc.

EMHTF

ENBL

ENLC

ENOB

FRONTERA ENERGY CORP ORD by Frontera Energy Corp

FECCF

FLNG

Stocks That Hit 52-Week Lows On Wednesday

AMADEUS IT GROUP SA ORD by Amadeus IT Group SA

Amadeus IT Group SA

Amadeus IT Group: Direct Connect Risk Not As Bad As It Seems

Shift4 CEO said to reject buyout bids as too low

ClearBridge International Growth EAFE Strategy Q1 2024 Portfolio Manager Commentary

ClearBridge International Growth ADR Strategy Q1 2024 Commentary

ClearBridge International Growth ACWI Ex-US Strategy Q1 2024 Commentary

Amadeus IT Group, S.A. Non-GAAP EPS of €0.74, revenue of €1.5B

Amadeus IT Group, S.A. 2024 Q1 - Results - Earnings Call Presentation

Amadeus IT Group, S.A. (AMADF) Q1 2024 Earnings Call Transcript

Amadeus: Remain Bullish As Growth Potential Remains Bright

Amadeus IT Group: Unreasonable Reasons For Not Taking Off Yet

AAGIY

AAIGF

AMADY

ASML

ASMLF

BNTX

CACG

CFCV

CMSQF

CMSQY

DAIUF

EDNMF

EDNMY

EPSN

EQBBF

FOUR

GVDNY

HKXCF

HKXCY

IBDRY

IBDSF

IDEXF

IDEXY

INFR

JHIUF

LRGE

LVMHF

LVMUY

MNDY

NONOF

NSRGF

NSRGY

PGPEF

PUBGY

RACE

SAFRF

SAFRY

SAPGF

SBGSF

SBGSY

SDVKF

SDVKY

SFTBF

SFTBY

SMMYY

SNEJF

SONY

SSDOF

SSDOY

STMNF

TOELF

TOELY

TSMWF

TSYHF

TSYHY

YLDE

ZLAB

ZLDPF

Amadeus IT Gr

<p><a href="https://amadeus.com/en/insights/press-release/expedia-groups-adoption-of-amadeus-ndc-technology-marks-another-step-in-driving-ndc-industry-wide" title="https://amadeus.com/en/insights/press-release/expedia-groups-adoption-of-amadeus-ndc-technology-marks-another-step-in-driving-ndc-industry-wide">https://amadeus.com/en/insights/press-release/expedia-groups-adoption-of-amadeus-ndc-technology-marks-another-step-in-driving-ndc-industry-wide</a></p>

Tech

EXPE

Amadeus Has Expanded A Strategic Partnership With Expedia Group, To Deploy New Distribution Capability Technology

<p>AMAG Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="/stock/AMAG#NASDAQ">AMAG</a>) today announced that NASDAQ has halted trading of the company&rsquo;s common stock. The U.S. Food and Drug Administration (FDA) Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) is meeting today to better understand and interpret&nbsp;the&nbsp;PROLONG (Progestin&rsquo;s Role in Optimizing Neonatal Gestation) trial&nbsp;data for Makena&reg; (hydroxyprogesterone caproate injection). The advisory committee meeting is scheduled to start at 8:15 a.m. ET. The briefing materials may be found on the FDA&rsquo;s website at <a href="https://www.globenewswire.com/Tracker?data=3-aJJG3cQhCuGplTwA5fGQrqIhgQii_6Z_PJH1m3WpLgUi5POP8LfrefE-zLcDgsQQAVd56v1khIZYRsaaEuu9aoFRvY_FEFKP904E-_OgR9QxY3XQqPHcl40V_y7GIdB65ykRSNP5fL6POiEp32AtOqax1jK9eHvJWBQh-U8U69sPjmtP7RXvNa7LLAjr_HsyfL3ntyiskbg4wS_JG8BtNEOZTDBpMKlAcjhvaxrQHVpYRRcVryOheakq3l94mJC2tBj3Mk4iRoo7hx0J0S8R25wTkCnI9Is-DyKNk-yGa7w9y-3AuoImSmDQ-y3yZFWH04qLuAV_Zo_l3UEk1d1sC9VIQboiIvQa7orDUWkv62ew19knczxgzkKCmOa4H81-R1Q0Kg43wFIRoCY4LtJs0Ws6uVryRGvnfZQm8_wmHqDQsHB0olebsh_Cm_1bEydz6GzyunkMTXiB88J4lsSUlN4yCRmFjJQAws_xe319g=" target="_blank">https://www.fda.gov/advisory-committees/advisory-committee-calendar/october-29-2019-meeting-bone-reproductive-and-urologic-drugs-advisory-committee-meeting-announcement</a>.</p>

Biotech

General

AMAG

AMAG Pharmaceuticals Says FDA Will Hold Meeting To 'better understand and interpret' PROLONG Trial Data For Makena

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

Amadeus IT Gr

News

Latest news for Amadeus IT Gr (OTC:AMADF) Stock

Tuesday, April 02, 2024

Wednesday, February 26, 2020

Tuesday, October 29, 2019